The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.
Blood Advances , Volume 4, pp 1192-1196; doi:10.1182/bloodadvances.2019001127
Abstract: The K666N mutation of SF3B1 has distinct clinicopathologic features in MDS. The K666N mutation of SF3B1 has a distinct RNA splicing profile.
Keywords: splicing / MDS / clinicopathologic / K666N mutation of SF3B1 / SF3B1 is associated
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Blood Advances" .